- Home
- DMAC vs TSVT Comparison
DMAC vs TSVT Comparison
Compare DMAC & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- TSVT
- Stock Information
- Founded
- DMAC 2000
- TSVT 2021
- Country
- DMAC United States
- TSVT United States
- Employees
- DMAC N/A
- TSVT N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- DMAC Health Care
- TSVT Health Care
- Exchange
- DMAC Nasdaq
- TSVT Nasdaq
- Market Cap
- DMAC 172.7M
- TSVT 160.4M
- IPO Year
- DMAC N/A
- TSVT N/A
- Fundamental
- Price
- DMAC $4.18
- TSVT $3.16
- Analyst Decision
- DMAC Strong Buy
- TSVT Buy
- Analyst Count
- DMAC 3
- TSVT 6
- Target Price
- DMAC $7.00
- TSVT $10.40
- AVG Volume (30 Days)
- DMAC 46.2K
- TSVT 339.4K
- Earning Date
- DMAC 11-13-2024
- TSVT 11-12-2024
- Dividend Yield
- DMAC N/A
- TSVT N/A
- EPS Growth
- DMAC N/A
- TSVT N/A
- EPS
- DMAC N/A
- TSVT N/A
- Revenue
- DMAC N/A
- TSVT $45,620,000.00
- Revenue This Year
- DMAC N/A
- TSVT N/A
- Revenue Next Year
- DMAC N/A
- TSVT $31.98
- P/E Ratio
- DMAC N/A
- TSVT N/A
- Revenue Growth
- DMAC N/A
- TSVT N/A
- 52 Week Low
- DMAC $2.14
- TSVT $1.68
- 52 Week High
- DMAC $4.95
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- DMAC 48.23
- TSVT 24.53
- Support Level
- DMAC $3.96
- TSVT $4.81
- Resistance Level
- DMAC $4.21
- TSVT $5.12
- Average True Range (ATR)
- DMAC 0.18
- TSVT 0.31
- MACD
- DMAC -0.02
- TSVT -0.16
- Stochastic Oscillator
- DMAC 50.00
- TSVT 6.67
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.